VRCA FY 2018 Earnings — Verrica Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

VRCAVerrica Pharmaceuticals Inc.

$57M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$20,294

Operating Income

-$22M

Net Income

-$21M

EPS (Diluted)

$-14.08

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$92M

Total Liabilities

$2M

Stockholders' Equity

$89M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$20,294	$0	—
Operating Income	-$22M	-$4M	-390.9%
Net Income	-$21M	-$4M	-363.1%